Correlation Between Leap Therapeutics and PIRS Old
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and PIRS Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and PIRS Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and PIRS Old, you can compare the effects of market volatilities on Leap Therapeutics and PIRS Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of PIRS Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and PIRS Old.
Diversification Opportunities for Leap Therapeutics and PIRS Old
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Leap and PIRS is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and PIRS Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PIRS Old and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with PIRS Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PIRS Old has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and PIRS Old go up and down completely randomly.
Pair Corralation between Leap Therapeutics and PIRS Old
Given the investment horizon of 90 days Leap Therapeutics is expected to under-perform the PIRS Old. In addition to that, Leap Therapeutics is 3.38 times more volatile than PIRS Old. It trades about -0.11 of its total potential returns per unit of risk. PIRS Old is currently generating about -0.11 per unit of volatility. If you would invest 1,745 in PIRS Old on November 2, 2024 and sell it today you would lose (385.00) from holding PIRS Old or give up 22.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 71.84% |
| Values | Daily Returns |
Leap Therapeutics vs. PIRS Old
Performance |
| Timeline |
| Leap Therapeutics |
| PIRS Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Leap Therapeutics and PIRS Old Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Leap Therapeutics and PIRS Old
The main advantage of trading using opposite Leap Therapeutics and PIRS Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, PIRS Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PIRS Old will offset losses from the drop in PIRS Old's long position.| Leap Therapeutics vs. Surrozen | Leap Therapeutics vs. Armata Pharmaceuticals | Leap Therapeutics vs. Pasithea Therapeutics Corp | Leap Therapeutics vs. Aditxt Inc |
| PIRS Old vs. Adaptimmune Therapeutics Plc | PIRS Old vs. Mereo BioPharma Group | PIRS Old vs. PDS Biotechnology Corp | PIRS Old vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |